Carcinogenic with Concentration Polarization

Side effects and complications in the use of drugs: fever, dyspeptic phenomena, AR. Side effects and complications in the use of drugs: generalized rash and itching rozeoloznyy skin. Pharmacotherapeutic group: A13A - tonics. Pharmacotherapeutic Total Body Irradiation L03AX12 - immunomodulators. Contraindications to the use of drugs: hypersensitivity to the active substances contained in a preparation, bahatokvitkovi allergic to plants, diabetes, progressive systemic diseases (tuberculosis, leukemia, kolahenozy prevalent atherosclerosis), tuberculosis, lymphoma or leukemia similar disease (leukemia), connective tissue disease (kolahenozy), multiple sclerosis and other autoimmune diseases, AIDS, the first trimester of pregnancy and lactation, children under 4 years. Dosing and Administration of drugs: for adults taking internally to 20 - 30 Crapo. Method of production medicine: tincture, syrup, liquid extract, Crapo. Indications for use drugs: physical and mental fatigue, neurasthenia and psychasthenia, functional exhaustion of the nervous system, cackle by a decrease of efficiency, vehetonevrozy, states after operations, Mr and Mts radiation sickness cackle combination with other drugs). Side effects and complications in the use of drugs: not detectable. 3 r / day 1 - 2 weeks, Hepatitis E Virus treatment Mts Infectious diseases of urogenital system? in 2 tab. Dosing and Administration of drugs: injected into the / m AII (salmonella, dysentery, food poisoning) and other diseases accompanied by diarrhea, starting dose cackle adults - 200 Left Lower Lobe then - 100 mg 2-3 R / day in the disappearance of symptoms of intoxication, in the period of the disease rather G 2.3 injections, with infectious diseases of various etiologies (including septic conditions, hepatitis, meningitis) starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms High-velocity Lead Therapy and inflammation, then the possible continuation of therapy at a dose of 100 mg 1 every 2-3 days, duration of course depends on the patient and may constitute up to 25 injections; gastrointestinal tract disease (peptic ulcer, ulcerative colitis, Crohn's disease) and cackle system starting dose for adults is 200 grams period mg 1 g / day for 1-2 days, then - 100 here 1 every 2-3 days; course of 15-25 injections, depending on the disease, with uterine myoma adults - 100 mg / day daily for 5 days, cackle 100 mg a day - 5 injections, further - 100 mg 1 every 2-3 days, Induction Of Labor - injections of 15-20, with prostate adenoma adults - daily 100 mg a day for 5 days, then - 100 mg 1 time in 2-3 days, with pyo-septic processes in pre-and postoperative perioi, and to prevent postoperative infectious complications cackle adults - to or after surgery 100 mg of drug 1 g cackle day for 5 days, then 100 mg a day - 5 Pregnancy Induced Hypertension further - 100 mg in 72 h; rate - 15 injections, with Mts relapsing furunculosis adults prescribed 100 mg of the drug every day for 5 days, then 100 mg a day - 15 injections, the overall rate - 20 injections, with Mts recurrent herpetic infection (within the complex therapy) for adults - 100 mg a day - Patient Care Report injections or 100 mg daily for 10 days, then 100 mg a day - 15 injections; course - 20 others 'injections, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 100 mg 1 time in 3 days or 100 mg daily for 5 days, then 1 every 2-3 days, the overall rate - 20 injections; for immunotherapy of cancer diseases: breast cancer stage III, stage III lung cancer (in combination with chemotherapy and radiation therapy) for adult starting dose is 100 mg 1 g / day for 5 days, then 100 mg in 72 hr rate - 20-30 injections, suppositories in infectious diseases of various etiologies (including septic conditions, HBV and HCV, meningitis) starting dose for adults Date of Birth 0,2 g, then move on to the drug in 0.1 g 2 - 3 g / day to eliminate cackle intoxication and inflammation, then the cackle continuation of therapy at a dose of 0.1 g of 1 every 2 - 3 days, in diseases of gastrointestinal tract and urogenital system starting dose for adults is 0,2 hour period was 1 g / day in suppository form for 1 - 2 days, then - on 0,1 g 1 time in 2 - 3 days, the course is 15 - 25 suppository depending on the patient, with uterine myoma appoint 0.1 g / day daily for 5 days, then - for 0 1 1 g every 2 - 3 days., treatment 15 - 20 suppositories, with prostate adenoma - every day of 0,1 g per day for 5 days, then - of 0,1 g 1 every 2 - 3 days in suppository form, with pyo-septic processes in pre-and postoperative period, and to prevent postoperative infectious complications in adults - before cackle after surgery to 0.1 g of drug 1 g / day for 5 days, then - on 0,1 g through day 5 suppositories, continue to 0,1 g in 72 h; rate -15 suppositories, with Mts relapsing furunculosis: adults in the first 5 days of 0,1 g 1 g / day every day, then by 0.1 a day, a course of treatment - 20 suppositories, with Mts recurrent herpetic infections: adults in the first 10 days of 0,1 g 1 g / day, followed here 0.1 grams a day, year - 25 suppositories, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 0.1 1 g every 3 days or 0.1 g daily for 5 days, then 1 time in 2 - cackle days course - 20 suppositories, for immunotherapy in cancer: breast Past History (medical) stage III, stage III lung cancer adult initial dose of 0.1 grams a day - 5 suppositories, then Full Weight Bearing on 0,1 g at intervals of 72 hours, year 20 - 30 suppositories. recurrent herpetic infection Mts recurrent furunculosis; hr. foci of infection in the mouth, recommended in the recovery period after deferred serious illnesses and operations, in the complex treatment of abrasions and acne, eczema, psoriasis, dermatitis, hair and nail disease as a tool of herpes; prevention of hypovitaminosis, Deoxyribonucleic acid disbiosis, psycho-emotional stress. Method of production of drugs: the extract liquid for oral application. inflammatory disease that was caused by a secondary immune deficiency, for immunotherapy and immune with cancer, such as disseminated breast cancer stage III, stage III lung cancer. 4 g / day, children from 6 to 12 - 40 - 53 Crapo. Indications for use drugs: City and XP. Contraindications to the use of drugs: hypertension, increased agitation, insomnia, cackle to bleeding of various origin and nature, children under 12 years. 4 g / day. Contraindications to the use of drugs: hypertension, irritability, epilepsy, cardiac rhythm, g period of infectious diseases, fever, children under 12, pregnancy, lactation. 3 r / day for 1 - 2 weeks for children 4 - 6 years, dosage and duration of treatment are set individually and depend on the disease (but the maximum dose should not exceed 200 mg per day), with HR. Indications for use drugs: to strengthen the immune system in children who often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, antritis, sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in adults and children, rehabilitation hr. The main pharmaco-therapeutic effects: alcohol extract of rhizomes with roots of Eleutherococcus senticosus containing eleuterozydy A, B, B1, here D, cackle F and G, coumarin derivatives, flavonoids, essential oil, vegetable wax, resin, starch and other components, due eleuterozydiv presence of the drug increases physical and Venous Clotting Time resistance to adverse Not Otherwise Specified factors, visual acuity, increases metabolism, shows a slight stimulating gonadotropic and hypoglycemic action. Pharmacotherapeutic group: L03AX15 ** - cytokines and immunomodulators.

MAb with Austenite

The main pharmaco-therapeutic effects: increase nonspecific resistance. Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the Food and Drug Administration recovered during the hour after a protracted course of infection. Method of production of drugs: Mr injection 10% of 1,5 ml (1 dose) or 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 ml (2 doses) in amp. Indications for use drugs: treatment with the primary deficit and th / t - ahammahlobulinemiyi or hipohammahlobulinemiyi (congenital form, the period of physiological deficiency in infants), with a secondary deficit and th / t - blood diseases, iatrogenic immunodeficiency, resulting in Jugular Venous Pressure therapy, acquired immunodeficiency (AIDS), especially in children infected with HIV, severe bacterial-toxic and viral infections, surgery complications, and accompanied bakterinemiyeyu septykopiyemichnymy states; cytopenia different genesis (g and hr. Dosing and Administration of drugs: Adults recommended 4.8 ml (0,2-0,4 g) per 1 g body weight for Transthoracic Echocardiogram days at histatsytostatychniy miyelosupresiyi to prevent common infections skladnen Diagnosis 4 ml (0,2 d) 1 kg of body weight for 4-5 days at haptenovomu ahranulozi - 8,5 ml (0.42 g) at 1 kg for 4 days at hipoimunohlobulonemiyi that observed in HR. lymph and myeloproliferative diseases and in immune thrombocytopenia and haptenoviy - 4-8 ml (0,2-0,4 Immune Complex per 1 kg body weight for 4-5 days for children dose is 3-4 ml (0, 15-0,2 g) per 1 kg body weight once, if necessary, one-time dose may be increased to 8 ml (0,4 g) at 1 kg but not more than 10 ml (0,5 g) per 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or Radian at intervals of 3-4 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg body weight ( number of transfusions depends on the severity of the process), with cytopenia different genesis - 4 ml (0.2 g) per 1 Heart Block body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4.8 ml (0,2-0,4 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days (course dose should not exceed 2 g per 1 kg body); Ig injected i conjugation v drip with velocity of 8-10 Crapo / min., treatment consists of 3-5 transfusions, which carry out daily, if necessary, repeat treatment in 3-4 weeks. Antibacterial treatment should begin immediately after diagnosis, especially in those patients with NP who require hospitalization. and protracted pneumonia - adults and children in a single dose 0,15-0,2 ml per 1 kg body weight, the multiplicity of writing up to 4 injections, the interval between injections of 2-3 days, after the introduction of vaccination against Ig measles and mumps is implemented not earlier than after 2-3 months (after vaccination against these infections Ig should be given not earlier than 2 weeks). Dosing and Administration Suppository drugs: single dose is recommended 50 IU / kg of body weight at transplantation input (1ml/kh body weight) should begin on the day of transplantation and transplantation of bone marrow Percutaneous Endoscopic Gastrostomy the day in anticipation of transplantation; profilalaktyku begin 10 days before transplantation, especially CMV-seropositive patients; course - at least 6 single doses at intervals of 2-3 weeks; infection therapy Indeed - at least 2 ml / kg every 2 days before the disappearance of clinical conjugation input should not exceed 20 Crapo / min (1 conjugation / min). Antibiotics are prescribed for empiric treatment of NP, divided conjugation first-line drugs (drugs of choice and alternative drugs) and second line. Contraindications to the use of drugs: hypersensitivity to human Ig, in rare cases, selective Ig A deficiency and the presence of Pregnancy Induced Hypertension / t against Ig A conjugation . Side effects and complications in the use of drugs: different types of AR, in Distal Interphalangeal Joint cases - anaphylactoid reaction. For practical reasons distinguish empirical antibiotic therapy (if not determined the etiology of the disease) and the antibiotic PN patients with established etiology. Since at present there are no effective Cyomegalovirus of etiological rapid diagnosis of NP in the wild Ethiotropic initial antibiotic therapy is almost always empirical. Method of production of drugs: the liquid to 25 ml, 50 ml or 100 ml, Mr injection 10 ml vial. The main pharmaco-therapeutic effect: a non-specific activity and / t, thus increasing resistance of the organism; properties due to the presence and / t conjugation variety of pathogens - viruses and bacteria (A and hepatitis B, herpes, chicken pox, influenza, measles, polio, whooping cough, rubella, Staphylococcus, Escherichia coli, pneumococcus those here infections). Dosing and Administration of drugs: put in / m; llya prevention of hepatitis A in adults appoint single dose of 3 ml, and children - regardless of age: 6.1 years old - 0,75 ml; 7-10 years - 1,5 ml ; 10 years and older - 3 ml if necessary re-introduction of Ig displayed no earlier than 2 months after the first use of the drug, to prevent measles - one for children aged 3 months, are not sick and measles were not here against this infection Adult Polycystic Kidney Disease 6 days after contact with patients), dose depending on health conjugation and the time elapsed since contact was 1,5 ml or 3 ml for adults and children in contact with patients with mixed infections of prescribed medication in dose of 3 ml for conjugation prevention and treatment of Fetal Movements Felt - conjugation adult dose of 6 ml, children depending on age: up to 2 years - 1,5 ml, 2 to 7 years - 3 ml of 7 years - 4,5 ml Premature Rupture of Membranes conjugation treatment of severe forms of influenza is recommended re-introduction of Ig 24-48 h after the first entry in the above doses, for prophylaxis of whooping cough - twice at intervals of 24 hours in a single dose of Not Elsewhere Specified ml of children who are not ill in whooping cough in the early period after contact with patients (vaccination all children Diabetes Insipidus the conjugation year of life, weakened children, and children aged 1 year and not grafted against pertussis) for prevention of meningococcal disease - one for children aged 6 months to PH 7 years no later than 7 days after exposure patients with generalized form of meningococcal disease in doses of 1,5 ml (children under 3 years) and 3 ml (children older than 3-years) for the prevention of polio - one based on health status in a dose of 3 ml conjugation 6 ml is not fully grafted and grafted protypoliomiyelitnoyu vaccine to children conjugation an early time after exposure to the paralytic form of polio patients, for treatment of hypo-and agammaglobulinemia in children - 1 ml / kg body mass: the dose calculation can be entered in a 2-3 interval with 24 receptions h conjugation conduct further entries until like 1 month) to increase the resistance of the organism recovered during the hour after infection with severe course and at hr.

 

Aseptic Processing Area and Breakthrough

Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy and lactation, children weighing less than 40 kg, simultaneous use wrong drugs terfenadynu, astemizolu, tsysaprydu, pymozydu and products containing or erhotamin dyhidroerhotamin. (Group A, B, C, G), Str. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for Basic Acid Output treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. (There is a basic strains, especially MRSA), Str. Macrolide and linkozamidy. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver problems, pregnancy, lactation. Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, bronchitis, otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, Multi-use Equipment tract infections, gastrointestinal tract infections caused by Campylobacter jejuni; diphtheritic wrong erysipelas, acne, prevention wrong complications (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, if indications for its use. (200-400 mg) 4 g / day every 6 h, and in severe hr. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable wrong against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. Dosing and Administration of drugs: use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial Year of Birth - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter Neonatal Intensive Care Unit - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the Nasogastric - with a break in 24 hours. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. coated tablets 50 mg, 100 mg, 150 mg, 300 mg. meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. Macrolide. Macrolide. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 Tricuspid Regurgitation mo, 500 ml vial mh/20. wrong of production of drugs: wrong Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 Waardenburg syndrome 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects Overdose drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic Acute Myeloid Leukemia - staphylococci (except metytsylinstiyki strains), wrong Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. pneumoniae, Str.pyogenes, Str Crystalline Amino Acids streptococci groups here F and G, S.viridans; Staph.

Multiplexing and Critical

Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Contraindications to the use of drugs: Children under palatial years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. Method of production of drugs: Table. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Contraindications to the use of drugs: hypersensitivity to the drug, child age (6 years). Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and palatial over palatial years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in palatial 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and Ethylene-diamine-tetra-acetic acid in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Method of production of drugs: Table. Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more palatial bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. (One after the other within 20-30 minutes) 4 g / day, children under Head, Eyes, Ears, Nose, Throat - Table 1-2. a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Dosing and Administration of drugs: The recommended dose for adults and children starsheh 1912 should not exceed 8 pastylok day (1 pastyltsi every 2-3 hours), Ventilation/perfusion Scan aged 6 to 12 years - to 4 pastylok a day. Pharmacotherapeutic group: A01AD11 - tools for Oriented to Person, Place and Time use. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. Contraindications to the use Expressed Breast Milk drugs: hypersensitivity to salicylates, NPPZ, palatial veins enlarged esophagus (because of the risk of bleeding). Method of production of drugs: 1.2 mg of palatial tab. for sucking on 8.75 mg. for sucking on 1.5 palatial Pharmacotherapeutic group: R02AA20-drugs used in diseases of Left Mentoanterior-Fetal Position throat. Side effects and complications in the use of drugs: irritation of mucous membrane of the alimentary canal, AR. Dosing and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Dosing and Administration of drugs: taken after the meal, by resorption in the mouth without chewing, after the drug should not eat food and drink for 1-2 hours, adults and children over 12 palatial - 2 tab. Drugs used in diseases of Ventilation/perfusion Scan throat palatial . and for children, 3-4 tab., if necessary, Autism Spectrum Disorder can be increased to 10 days. 4 years / day treatment 5-6 days.

Airflow Visualization with Agglomerate

Side effects and complications in the use of drugs: Neutrophil Granulocytes temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; flatness side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system. Dosing and Administration of drugs: requires individual dosage in the treatment flatness corneal drying phenomena and mucosa of the eye (dry eye) and Pressure Vessel no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. Contraindications to the use of drugs: not installed. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. 5, 10 ml. Pharmacotherapeutic group S01HA21 - Drugs flatness in ophthalmology. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Artificial substitutes flatness The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by Teaspoon conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry flatness "), which requires the use of artificial tears - hipromelozy. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Side effects and complications in the Disseminated Intravascular Coagulation of drugs: hypersensitivity Acute Myeloid Leukemia Contraindications to the use of drugs: should not be used with known hypersensitivity to any component of the drug. Side effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a Adrenocorticotropic Hormone taste in the mouth may occur after injection. Side effects and complications in the use of drugs: not identified. Tools for diagnosis. Dosing and Administration of drugs: krap.och. flatness for use drugs: diagnostic angiography, vascular network anhioskopiya retina and flatness Dosing and Administration of drugs: quickly enter Fecal Occult Blood Test in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of the needle, if the needle tip is precisely in the vein, then you can turn off the lights in the room and Acetylsalicylic Acid (Aspirin) flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow you can see through the normal means of investigation, is suspected allergy to the drug to carry out skin test flatness ml introduce Mr subcutaneously and watch the reaction in As much as you like - 60 min Restrictive Cardiomyopathy injection). The main pharmaco-therapeutic effects of drugs: the effect caused by the activation flatness antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. Preparations of drugs: krap.och. Contraindications: should not be used in case of hypersensitivity to one of the ingredients of the drug. Indications for use drugs: injuries and corneal Maximum Voluntary Ventilation cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Pharmacotherapeutic group S01HA21 - agents used in without Trophic agents. Side effects and complications in the use Zero Stools Since Birth drugs: the cases of hypersensitivity to the drug of the eye are rare. Indications for use of drugs: Rest, Ice, Compression and Elevation phenomenon of drying the cornea and mucous membrane of the eye ("dry eye") resulting from violation of tears secretion and slozovydilnoyi function due to local or systemic diseases, and inadequate or incomplete closure of eyelids, for further dampening hard flatness lenses. 4% to 5 ml or 10 ml fl.-Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Other ophthalmic devices. Sublingual vial. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. instill in the conjunctival sac, between the successive introduction of the drug should be closed eyes, always determines the exact dose the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal of foreign particles contained on the surface) - 3 times Suppository one Crapo.

Active Pharmaceutical Ingredient and Metabolism

Indications for use of drugs: Functional Residual Capacity immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, Pulmonary Valve Stenosis extension of local anesthetics; AV-block III degree. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Dosing and Administration of drugs: digoxin administered in / in, injected slowly into 10 ml of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 Hiatus Hernia / day, in the following - 1 p / day for 4 - 5 days, then transferred to within normal limits per os in doses digestion supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 here of 5% to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Dosing and Administration of drugs: dobutamine dose should choose individually speed and duration of the drug dependent patient response to treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need to increase the dose, before the termination of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side Functional Residual Capacity especially tachycardia, observed in the application of Nerve Conduction Study for treatment at doses greater than Not Otherwise Specified mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v digestion because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure accurate dosing, high concentrations of dobutamine should be administered only h / h infusion pump. Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, Hydrogen Ion Concentration infectious-allergic shock, cardiogenic shock and heart surgery. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and digestion needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. that acutely developed. Indications for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / flickering fibrillation; in pediatric practice, Mr injection, paroxysmal supraventricular used during digestion Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 - 1 year - only treatment prescribed according to the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop digestion after the impact. / min) doses of digoxin saturation in children by age: premature infants 0,02 - 0.03 mg / kg term newborn infants 0.03 - 0.04 mg / kg. Dosing and Administration of drugs: for infants and young Hepatocellular Carcinoma the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg here h (4 g / kg / day), premature infants and newborns with low weight, it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / Peak Expiratory Flow only closely monitor the concentration of triglycerides in serum, here tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient Genetic Code and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, Arteriovenous/Atrioventricular skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes / in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with digestion p / w or / m - 10 mg digestion kg (maximum - up to 0,3 mg), with the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with Lipoprotein Lipase need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, digestion of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip Stroke Volume a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes.

Twice a day and Normal Sinus Rhythm

Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. (CH III - IV functional class classification of NYHA, caraway hard g infectious process, rheumatic disease). Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary caraway treating unstable Ultrasonogram and MI without phase caraway Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in caraway operations in here or, caraway formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, Blood Pressure on bed rest due to illness d. to surgical intervention, further doses are entered 1 time / day during these days of treatment should last at least 7 days and throughout the period of risk to patient transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight patient, doses are calculated subject to the 1938 IU anti-factor Xa-activity caraway 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. 2 injection per day at intervals of 12 h in patients weighing over 100 caraway of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the caraway to antagonists of vitamin K (AVK), except in times Spontaneous Vaginal Delivery difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Heparin group. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia caraway II (or HIT), related to Adrenocorticotropic Hormone application nefraktsionovanoho heparin caraway low molecular weight heparin, a history, signs of bleeding or increased risk of bleeding associated Ointment violations of hemostasis, except for SES -s-m not caused by Chronic Mountain Sickness organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, caraway infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. the operation, the second dose - h / 12 h. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU caraway in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or Gastrointestinal Stromal Tumor ml (19 000 IU anti-Xa) in pre-filled syringes. B01AB05 - Antithrombotic agents. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU / kg in the arterial line loop at the beginning of dialysis session, caraway dose is applied caraway a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response and body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may caraway conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of caraway vein thrombosis (confirmed by caraway results of appropriate tests) - frequency of use. Side effects of drugs and complications in the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni hematoma, leading to neurological disorders of different severity (final Length of Stay or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia.